Alphatec said it agreed to settle a legal dispute with OrthoTec for $49 million paid over 7 years and meets Wall Street's expectations for its 4th-quarter earnings.
Alphatec (NSDQ:ATEC) said it agreed to pay $49 million over 7 years to settle a legal dispute with OrthoTec and beat Wall Street's forecast for its 4th-quarter earnings.
Shares of Cantel Medical come under pressure despite strong fiscal 2nd-quarter results that beat expectations on Wall Street.
Cantel Medical (NYSE:CMN) shares are down nearly 4% this morning after the medical device company reported its fiscal 2nd-quarter results.
Medical lasers maker Biolase is still examining "strategic alternatives" for the company as its slashes about $1.3 million from its payroll and posts continued quarterly losses.
California medtech company Biolase (NSDQ:BIOL) is looking to slim down ahead of a potential acquisition as the company examines its "strategic alternatives."
The medtech giant formed by the merger of Kinetic Concepts, LifeCell Corp. and Systagenix swings to the red in Q4 amid a near 7% boost in sales.
The newly formed medtech alliance comprised of Kinetic Concepts, LifeCell and Systagenix posted collective figures that put the group in the red for Q4, a recent SEC filing shows.
Shares of NuVasive jump on Wall Street today after the medical device company reports earnings ahead of analysts' expectations.
NuVasive Inc. (NSDQ:NUVA) shares gained nearly 8% today after the medical device company reported beating expectations with its 4th-quarter earnings as it swung to black ink.
Endo Health Solutions says the attorneys general from several states including California are investigating its pelvic mesh products; 4th-quarter earnings beat expectations, but Endo's outlook disappoints Wall Street.
Endo Health Solutions (NSDQ:ENDP) said its pelvic mesh products are under investigation by the attorneys general from several states including California.
Diabetes devices maker Insulet posts a stellar quarter that beats Wall Street's expectations and notes a pending Massachusetts Attorney General inquiry.
Massachusetts-based Insulet (NSDQ:PODD) got some Wall Street love today after posing a significant bump in sales for its 4th quarter and the full year of 2013.